3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
44
Observational
3
Sponsor
Cancer Type
Dermatologic
3
Conditions
Melanoma
3
Interventions
Blood Specimen Collection
14
Nivolumab
13
Ipilimumab
12
pembrolizumab
11
trametinib
9
Surveys and Questionnaires
9
Gene Expression Profiling
9
dabrafenib
8
Biopsy
6
Specimen Handling
5
Immunotherapy
5
Immunohistochemistry
5
Amplified Fragment Length Polymorphism Analysis
4
encorafenib
3
binimetinib
3
atezolizumab
3
Restraint, Physical
3
Quality of Life
3
Polymerase Chain Reaction
3
Introns
3
Flow Cytometry
3
Drug Therapy
3
Data Collection
3
tremelimumab
2
pimonidazole
2
cobimetinib
2
aldesleukin
2
Watchful Waiting
2
Vemurafenib
2
Therapeutics
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Melanoma
×
binimetinib
×
Clear all
NCT07022457
2026-04-13
UK-EnBiRiM
Pierre Fabre Ltd
Active not recruiting
50 enrolled
NCT05260684
2025-03-06
OCEANMIST
Pfizer
Completed
716 enrolled
10 charts
NCT04045691
2021-01-19
BERING
Pierre Fabre Pharma GmbH
Recruiting
750 enrolled